|
Rheumatoid Arthritis
Citations 261-270 of 841 total displayed.
|
Past content
(since Feb 2000):
|
- MATTERS ARISING
Comment on: Arthritis as presenting manifestation of pure neuritic leprosy—a rheumatologist's dilemma
- H. M. Al Attia
Rheumatology 2008; 47: 110-b--b111.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: Arthritis as presenting manifestation of pure neuritic leprosy—a rheumatologist's dilemma: reply
- N. Haroon, A. Aggarwal, R. Misra, N. Kumari, N. Krishnani, and V. Agarwal
Rheumatology 2008; 47: 111-112.
[Extract]
[Full Text]
- EDITORIALS
Regulators of cytokine signalling in rheumatoid arthritis
- A. Rahman
Rheumatology 2007; 46: 1745-1746.
[Extract]
[Full Text]
- BASIC SCIENCE
Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation
- C. E. Vergunst, D. M. Gerlag, H. Dinant, L. Schulz, M. Vinkenoog, T. J. M. Smeets, M. E. Sanders, K. A. Reedquist, and P. P. Tak
Rheumatology 2007; 46: 1773-1778.
[Abstract]
[Full Text]
- CLINICAL
Blockade of tumour necrosis factor- in rheumatoid arthritis: effects on components of rheumatoid cachexia
- G. S. Metsios, A. Stavropoulos-Kalinoglou, K. M. J. Douglas, Y. Koutedakis, A. M. Nevill, V. F. Panoulas, M. Kita, and G. D. Kitas
Rheumatology 2007; 46: 1824-1827.
[Abstract]
[Full Text]
- CLINICAL
The role of HLA-DRB1 shared epitope alleles in predicting short-term response to leflunomide in rheumatoid arthritis
- G. Saruhan-Direskeneli, M. Inanc, I. Fresko, N. Akkoc, E. Dalkilic, E. Erken, Y. Karaaslan, G. Kinikli, F. Oksel, S. Pay, E. Yucel, S. P. Yentür, J. Duymaz-Tozkir, V. Yilmaz, N. Inanc, H. Yazici, M. Konice, and H. Direskeneli
Rheumatology 2007; 46: 1842-1844.
[Abstract]
[Full Text]
- LETTERS TO THE EDITOR
Adherence to immunosuppressant drugs in patients with connective tissue diseases
- D. Pyne and K. Chaabo
Rheumatology 2007; 46: 1859-a.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF- agents: the Newcastle (UK) experience
- V. V. Kaushik, S. Ambalavanan, and K. Binymin
Rheumatology 2007; 46: 1863-1864.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: Use of the QuantiFERON-TB® Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF- agents: the Newcastle (UK) experience: reply
- A. Pratt, K. Nicholl, and L. Kay
Rheumatology 2007; 46: 1864-1865.
[Extract]
[Full Text]
- EDITORIALS
Is it ever appropriate to discharge patients with rheumatoid arthritis?
- M. Bukhari, A. N. Bamji, and C. Deighton
Rheumatology 2007; 46: 1631-1633.
[Extract]
[Full Text]
|
|
